Services are designed for regulated life sciences organizations, including pharmaceutical and biotechnology companies, sponsors, CROs, CMOs, CDMOs, research institutions, clinical sites, laboratories, manufacturers, distributors, pharmacovigilance organizations and technology or service providers supporting GxP activities.

Engagements may cover GCP, GMP, GLP, GVP, GDP, quality systems, data integrity, computerized systems, sponsor oversight, vendor oversight, inspection readiness, CAPA, training and governance. The exact scope is agreed according to the organization’s activities and regulatory responsibilities.

Services can be aligned, as relevant, with applicable expectations and good practices associated with authorities and frameworks such as EMA, FDA, MHRA, WHO, ICH and PIC/S. The engagement is not presented as an official authority review or endorsement.

Yes. The scope can be adapted for early-stage biotechnology companies, developing sponsors, specialist laboratories, individual sites, multinational organizations and complex outsourced operating models.

The scope is normally defined through an initial discussion and, where needed, a focused review of relevant background information. Key considerations include:

• The business and compliance objective
• Applicable GxP domains and regulatory markets
• Products, studies, facilities, systems or vendors involved
• Known findings, risks and time constraints
• Expected deliverables and stakeholder needs

No. Independent assessment, remediation support and training can strengthen readiness and help organizations address identified risks, but no consultant can guarantee regulatory approval, accreditation or a particular inspection outcome.

Audit support can include GCP, GLP, GMP, GVP, vendor and service provider audits, TMF audits, data integrity and computerized systems audits, for-cause audits and focused audits of specific processes or risks.

Review the complete Inspection & Audits services .

Yes. Depending on the objective, evidence, system access and regulatory risk, audits may be delivered remotely, on site or through a hybrid model. Some operational, facility or manufacturing risks may require direct on-site observation.

Pre-audit information may include organizational charts, procedures, quality manuals, process descriptions, system inventories, quality agreements, previous findings, metrics, training records and selected operational evidence. A tailored request list is normally prepared for the engagement.

Deliverables depend on scope but may include an executive summary, audit scope and methodology, evidence reviewed, observations, risk classification, supporting rationale, systemic themes and practical recommendations for follow-up.

Yes. Inspection-readiness support can include gap assessment, document review, mock inspection activity, interview coaching, inspection governance, evidence-retrieval testing, observation management and remediation planning aligned with the relevant regulatory context.

Yes. A focused independent review can evaluate whether the response addresses the observation, investigation scope, systemic root cause, immediate correction, CAPA, implementation evidence, commitments and effectiveness measures.

Yes. Support may include remediation strategy, finding consolidation, root cause challenge, CAPA design, action sequencing, governance, evidence review, progress reporting, effectiveness verification and residual-risk assessment.

Related services are available under Quality Systems & Remediation .

Yes. CAPAs can be reviewed for alignment with the identified problem, root cause, systemic scope, risk, implementation feasibility, ownership, due dates, evidence requirements and effectiveness criteria.

Yes. Support may include SOP architecture, process mapping, drafting, revision, document hierarchy, approval workflows, implementation planning and alignment with the organization’s quality-management system.

Yes. A quality-system gap assessment can examine governance, document control, training, deviations, CAPA, change control, risk management, vendor oversight, management review, metrics, computerized systems and other applicable processes.

No. Training is appropriate when a genuine knowledge, skill or understanding gap contributed to the issue. It should not be used as a default substitute for correcting weak procedures, system design, resources, supervision, governance or other systemic causes.

Effectiveness should be evaluated using evidence linked to the original problem and expected control outcome. This may include record review, trend analysis, repeat audit, process metrics, observation of practice, system data or confirmation that recurrence risk has been reduced.

Yes. Support can cover vendor qualification, delegated responsibility mapping, governance meetings, quality agreements, performance indicators, escalation, audit strategy, issue management and evidence of ongoing sponsor oversight.

External QA Leadership provides senior quality expertise when an organization requires independent guidance, temporary leadership capacity or specialist support without immediately appointing a permanent internal executive.

Yes. Executive QA Advisory can translate complex findings, inspection exposure, remediation risk, governance concerns and quality-system weaknesses into clear implications and decision options for senior leadership or boards.

Yes. Due diligence may evaluate inspection history, quality systems, open findings, regulatory commitments, vendor risk, data integrity, manufacturing or clinical exposure, remediation requirements and potential post-transaction integration needs.

Yes. Quality agreements can be developed or reviewed to clarify GxP responsibilities, communication, deviations, changes, audits, records, complaints, recalls, data ownership, escalation and governance between contracting parties.

Yes. Support can be structured as a defined project or an ongoing advisory arrangement involving regular governance meetings, quality-risk review, management reporting, program challenge and escalation support.

See the complete Governance & Oversight services .

Yes. Training may be adapted to internal procedures, terminology, systems, quality events, regulatory context, workforce roles and identified capability gaps, subject to the agreed scope and availability of source information.

Training primarily develops knowledge and capability. A workshop is more interactive and is normally built around a defined organizational challenge, using facilitated discussion, scenarios, process analysis and practical decisions.

Yes. Inspection Interview Coaching can help subject-matter experts, leaders and support teams practice accurate, evidence-based responses, understand interview discipline and manage uncertainty, clarification and escalation appropriately.

Yes. Training and workshops may be delivered virtually, on site or through a hybrid model. The appropriate format depends on audience size, geography, confidentiality, learning objectives and the level of practical interaction required.

Depending on risk and scope, effectiveness can be evaluated through knowledge checks, scenario analysis, practical exercises, facilitated discussion, observation of performance, process metrics or post-training record review.

Where included in scope, deliverables may include the agenda, learning objectives, training materials, attendance information, assessments, exercise records, participant feedback and follow-up recommendations.

Explore all Training & Support services .

Yes. Confidentiality arrangements can be established before sensitive information is exchanged. Engagement documentation can define permitted use, access, disclosure and handling of confidential materials.

Yes. A mutual or client-provided confidentiality agreement may be reviewed and executed as appropriate before detailed documents, findings, product information or transaction data are shared.

Timing depends on scope, urgency, resource availability, contracting, access to evidence and travel requirements. For urgent inspection, remediation or quality-risk matters, the initial phase may be structured around the most critical priorities.

Fees depend on the nature and complexity of the work, number of sites or systems, document volume, stakeholder requirements, travel, reporting expectations and delivery timeline. A defined proposal or scope of work is normally provided before the engagement begins.

Yes. Complex engagements can be divided into phases such as initial risk assessment, detailed review, implementation support, effectiveness evaluation and ongoing governance. This can help prioritize urgent exposure while maintaining a structured long-term plan.

The next step is usually clarification of scope, stakeholders, timing, required evidence, delivery model and expected outputs. Where appropriate, a written proposal or statement of work is then prepared for review.